Selected article for: "additional drug and machine learning"

Author: Krämer, Andreas; Billaud, Jean-Noël; Tugendreich, Stuart; Shiftman, Dan; Jones, Martin; Green, Jeff
Title: The Coronavirus Network Explorer: Mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function
  • Cord-id: r6d70bci
  • Document date: 2020_9_14
  • ID: r6d70bci
    Snippet: Building on recent work that identified human host proteins that interact with SARS-CoV-2 viral proteins in the context of an affinity-purification mass spectrometry screen, we use a machine learning-based approach to connect the viral proteins to relevant biological functions and diseases in a large-scale knowledge graph derived from the biomedical literature. Our aim is to explore how SARS-CoV-2 could interfere with various host cell functions, and also to identify additional drug targets amon
    Document: Building on recent work that identified human host proteins that interact with SARS-CoV-2 viral proteins in the context of an affinity-purification mass spectrometry screen, we use a machine learning-based approach to connect the viral proteins to relevant biological functions and diseases in a large-scale knowledge graph derived from the biomedical literature. Our aim is to explore how SARS-CoV-2 could interfere with various host cell functions, and also to identify additional drug targets amongst the host genes that could potentially be modulated against COVID-19. Results are presented in the form of interactive network visualizations, that allow exploration of underlying experimental evidence. A selection of networks is discussed in the context of recent clinical observations.

    Search related documents:
    Co phrase search for related documents
    • absolute value and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • absolute value and machine learning: 1, 2, 3, 4, 5
    • absolute value and machine learning model: 1
    • activation inhibition and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6
    • activation inhibition and machine learning: 1, 2
    • activation inhibition and machine learning model: 1
    • activation status and acute ards respiratory distress syndrome: 1
    • activation status and machine learning: 1, 2
    • acute ards respiratory distress syndrome and additional context: 1, 2
    • acute ards respiratory distress syndrome and low lymphocyte count: 1, 2
    • acute ards respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute ards respiratory distress syndrome and machine learning model: 1, 2
    • additional context and machine learning: 1, 2, 3
    • additional context provide and machine learning: 1
    • additional gene and machine learning: 1
    • adjacency matrix and machine learn model: 1
    • adjacency matrix and machine learning: 1
    • adjacency matrix and machine learning model: 1